Gossamer Bio, Inc. Common Stock GOSS

$0.17 +2.42% at last close
Market Cap$84.86 million
P/E Ratio
Div Yield
Volume17.71M
52-Week Range $0.11$3.87

Key Stats

Today's Range
$0.16 $0.18
50-Day Range
$0.11 $0.27
52-Week Range
$0.11 $3.87
Volume
17.71 million shs
Average Volume
36.80 million shs
Market Cap
$84.86 million
P/E Ratio
Dividend Yield

Valuation

P/E Ratio
Price / Book
-0.53
Price / Sales

Short Interest

Short Interest
0.06%
Days to Cover
1.00

About Gossamer Bio, Inc. Common Stock

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Sector
PHARMACEUTICAL PREPARATIONS
Employees
162
Exchange
XNAS
Listed
2019-02-08

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.